Crossref
Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem
Diabetes & Obesity International Journal · 2016
DOI: 10.23880/doij-16000117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Obesity International Journal, 2016. Verfasst von Ricardo ET Navarrete. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Navarrete, R. E. (2016). Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem. Diabetes & Obesity International Journal. https://doi.org/10.23880/doij-16000117
Vancouver
Navarrete RE. Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem. Diabetes & Obesity International Journal. 2016. doi:10.23880/doij-16000117
BibTeX
@article{Navarrete2016,
author = {Navarrete, Ricardo ET},
title = {Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem},
journal = {Diabetes & Obesity International Journal},
year = {2016},
doi = {10.23880/doij-16000117}
}
EUVIMED